Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
1.870
+0.010 (0.54%)
At close: Oct 9, 2026, 4:00 PM EDT
1.861
-0.010 (-0.51%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $107.12 million as of October 9, 2026. It is the 24,982nd most valuable company in the world and the 4,071st biggest in the United States. Its market cap has decreased by 65.79% in one year.
Market Cap
107.12M
Enterprise Value
-10.86M
1-Year Change
-65.79%
Global Rank
Country Rank
#4,071 United States
Category
ChartMarket Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has decreased from $110.17M to $107.12M, a decrease of -2.77%. That is a compound annual growth rate of -0.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 107.12M | -78.34% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 112.59M |
| Immunic | 111.75M |
| Rani Therapeutics Holdings | 111.38M |
| Conexeu Sciences | 109.72M |
| Milestone Pharmaceuticals | 107.80M |
| Tevogen | 106.69M |
| Black Diamond Therapeutics | 105.14M |
| Aardvark Therapeutics | 104.17M |